VivArt-X receives the MIT Feasibility study 2023

Funding news!

VivArt-X has been awarded the MIT feasibility study grant (“MIT Haalbaarheidsprojecten”) by the Province of North Brabrant (Stimulus Programmamanagement).
This project focuses on the technical development and the investigation of the potential market validation of a novel medical technological platform for breast tissue regeneration.
The funding will enable VivArt-X to analyze potential challenges and refine the technology’s implementation. MIT Zuid’s support has been crucial in promoting regional innovation and progress.